Welcome, this website is intended for international healthcare professionals with an interest in the treatment of Advanced Prostate Cancer. By clicking the link below you are declaring and confirming that you are a healthcare professional

You are here

INTERVIEW WITH PROF. MILLER AT DGU 2013

Interview with Prof. Miller

Update from the Meeting of the German Urological Association in Dresden: meta-analysis shows advantages of LHRH-antagonists in terms of cardiovascular side effects, new data from the abiraterone EAP in Germany, ongoing discussion on sequencing.

The content of the videos, articles and all statements expressed therein do not necessarily reflect the opinions or views of the Editors, Authors or Reviewers of European Urology.